Copy number variation analysis in The Cancer Genome Atlas identified NTAQ1 as a potential driver of HCC progression. NTAQ1 accelerates tumor growth by promoting the degradation of the tumor suppressor protein PRDM2, thereby impairing DNA repair and suppressing apoptosis. These findings indicate that NTAQ1 could be a valuable target for the treatment of
Tomohiko Ikehara +21 more
wiley +1 more source
Peutz-Jeghers syndrome with concurrent lobular endocervical glandular hyperplasia and sex cord tumor with annular tubules: a case report. [PDF]
Yin M, Lu C, Cheng L.
europepmc +1 more source
F3/TF‐high ovarian clear cell carcinoma exhibits an immune‐cold phenotype characterized by reduced immune‐cell fractions and attenuated cancer‐cell interferon programs, with frequent B7‐H4 co‐expression. Patient‐derived models show preclinical sensitivity to the TF‐directed antibody–drug conjugate tisotumab vedotin.
Yutaro Mori +7 more
wiley +1 more source
Feasibility and Outcomes of a Robotic Retroperitoneal Approach to Para-Aortic Lymphadenectomy in Intermediate- and High-Risk Endometrial Cancer: A Prospective Study. [PDF]
Kubo-Kaneda M +6 more
europepmc +1 more source
Mice expressing only mutant PTEN Y138L, a protein which shows normal suppression of cellular AKT yet lacks protein phosphatase activity, die in utero, and heterozygous mice display a range of tumors. This indicates both the lipid and protein phosphatase activities of PTEN work together for normal tumor suppression and embryonic development.
Priyanka Tibarewal +16 more
wiley +1 more source
MRI-Based Habitat Radiomics for Differentiating Early-Stage Endometrial Carcinoma from Submucous Leiomyoma: A Multicenter Validation Study. [PDF]
Tian H +7 more
europepmc +1 more source
Update on Menopause Hormone Therapy; Current Indications and Unanswered Questions
ABSTRACT Objective To provide clinicians involved in managing menopause with a summary of current evidence surrounding menopause hormone therapy (MHT). Design The authors evaluate and synthesize existing pooled evidence relating to MHT's clinical indications, efficacy, and safety and explore the limitations of existing data. Patients The review focuses
Annice Mukherjee, Susan R. Davis
wiley +1 more source
Evolutionary perspectives on endometrial cancer: antagonistic pleiotropy. [PDF]
Kobayashi H.
europepmc +1 more source
Isolated axillary metastasis from early-stage dMMR endometrial carcinoma: a case report and mini-review. [PDF]
Yu Y, Chang X, Hou X, Zhang F.
europepmc +1 more source
Optical coherence tomography enables optical biopsy of endometrial tissue for early cancer detection. [PDF]
Thakur S +15 more
europepmc +1 more source

